Volume 46.dollar5Interferon treatment of human neoplasia /
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York :
Name of Publisher, Distributor, etc.
Academic Press,
Date of Publication, Distribution, etc.
1986.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (265 pages) :
Other Physical Details
illustrations.
SERIES
Series Title
Advances in cancer research ;
Volume Designation
v. 46
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Front Cover; Advances in Cancer Research: Interferon Treatment of Human Neoplasia; Copyright Page; Contents; Preface; Chapter 1. Interferons (IFNs); I. Introduction; II. Types; III. Production and Purification; IV. Induction and Production Control; V. Genetics; Chapter 2. General Action; I. Action on Cells in General; II. Action on the Cell Surface; III. Tumor Viruses and Oncogenes; IV. Biological Response Modifiers; V. IFNs and Prostaglandins; Chapter 3. Anti-Growth Effects; I. The Anti-Growth Concept; II. Anti-Growth Effects in Tissue Culture; III. Colony Techniques
Text of Note
Chapter 7. Animal Tumor ModelsText; Chapter 8. Treatment of Human Papillomavirus-Associated Tumors; I. Local Treatment of Human Papillomavirus-Associated Tumors; II. IFN Treatment of Juvenile Laryngeal Papillomatosis; III. Systemic IFN Treatment of Other HPV-Associated Tumors; Chapter 9. Regional Treatment of Other Tumors; I. Intra- and Peritumoral IFN Therapy; II. Local Treatment of Malignant Melanoma; III. Local Treatment of Breast Cancer; IV. Local Treatment of Cancer of the Uterine Cervix; V. Local Treatment of Neurological Tumors; VI. Local Treatment of Head and Neck Tumors
Text of Note
IV. Theory behind the Anti-Growth ConceptV. Nude Mouse Experiments; Chapter 4. Effects on the Immune System; I. General Effects; II. IFNs and NK Cells; III. Other Effector Systems; IV. Immunoregulatory Circuits; Chapter 5. Effects on Other Parameters; I. Receptors and Somatic Antigens; II. Tumor Cell Antigens and Other Markers; III. Various Laboratory Parameters; Chapter 6. Pharmacology and Toxicity; I. IFN Effects in Animals-General Implications; II. Animal Toxicity; III. IFN Titrations and Pharmacokinetics; IV. Anti-IFN Antibodies.; V. Side Effects and Toxicity; VI. IFN and Disease
Text of Note
VII. Local Treatment of Lung TumorsVIII. Local Treatment of Bladder Tumors; IX. Intraarterial IFN Therapy; Chapter 10. Systemic Therapy of Indignant Disease; I. Systemic IFN Therapy of Tumors-Screening Trials; II. Systemic Treatment of Leukemias; III. Systemic Treatment of Lymphomas; IV. Systemic Treatment of Myelomatosis; V. Systemic Treatment of Kaposi's Sarcoma; VI. Systemic Treatment of Soft Tissue Sarcomas; VII. Systemic Treatment of Osteosarcomas; VIII. Systemic Treatment of Malignant Melanoma; IX. Systemic Treatment of Renal Cell Carcinoma; X. Systemic Treatment of Lung Cancer
Text of Note
XI. Systemic Treatment of Gastric CancerXII. Systemic Treatment of Colorectal Carcinoma; XIII. Systemic and Intraarterial IFN Treatment of Liver Cancer; XIV. Systemic Treatment of Carcinoids; XV. Systemic Treatment of Nasopharyngeal Carcinoma; XVI. Systemic Treatment of Brain Tumors; XVII. Systemic Treatment of Neuroblastoma; XVIII. Systemic Treatment of Prostate Carcinoma; XIX. Systemic Treatment of Carcinoma of the Uterine Cervix; XX. Systemic Treatment of Ovarian Carcinoma; XXI. Systemic Treatment of Breast Cancer; Chapter 11. Inducers; Text; Chapter 12. Other Forms of IFN Therapy
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
ADVANCES IN CANCER RESEARCH, VOLUME 46.
OTHER EDITION IN ANOTHER MEDIUM
Title
Advances in cancer research. Volume 46. Interferon treatment of human neoplasia.